Source:Â Asthma and Respiratory Foundation
The first-ever New Zealand COPD (Chronic Obstructive Pulmonary Disease) Guidelines have been published in the New Zealand Medical Journal today, providing a national framework for diagnosis and management of COPD in a New Zealand context.
Affecting more than 15% of New Zealand adults over the age of 45, and encompassing emphysema, chronic bronchitis, and chronic airflow obstruction, COPD is irreversible and usually progressive. People with COPD are more at risk to severe illness from contracting COVID-19, as listed on the Ministry of Healthâs website of severe underlying medical conditions.
The guidelines have been developed by the Asthma and Respiratory Foundationâs (ARFNZ) working group of respiratory health experts led by Dr Stuart Jones from Middlemore Hospital and Professor Bob Hancox from the University of Otago, with the goal of improving diagnosis, and laying out clear recommendations for assessment and management of t
Friday, 19 February 2021, 9:10 am
The first-ever New Zealand COPD (Chronic Obstructive
Pulmonary Disease) Guidelines have been published in the New
Zealand Medical Journal today, providing a national
framework for diagnosis and management of COPD in a New
Zealand context.
Affecting more than 15% of New
Zealand adults over the age of 45, and encompassing
emphysema, chronic bronchitis, and chronic airflow
obstruction, COPD is irreversible and usually progressive.
People with COPD are more at risk to severe illness from
contracting COVID-19, as listed on the Ministry of Health s
website of severe underlying medical conditions.
The
guidelines have been developed by the Asthma and Respiratory